ArticleComputational and structural biotechnology journal2025
Artificial intelligence insight on structural basis and small molecule binding niches of NMDA receptor.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global trends and research hotspots in autoimmune encephalitis: insights from a bibliometric and visualized analysis: 1971-2025.Frontiers in immunology · 2026Pooled it
- From synapse to strategy: a bibliometric map of ionotropic glutamate receptors in depression.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis.Journal of Alzheimer's disease : JAD · 2026Article
- Global hotspots and trends in AMPA receptor research (2000-2025): a bibliometric and visualization analysis.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Mapping the evolution of kainate receptor research over five decades: trends, hotspots, and emerging frontiers.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NMDA receptors are critical to neuronal activity and play essential roles in synaptic transmission, learning, and memory. Despite significant advances in X-ray crystallography and cryo-electron microscopy (cryo-EM), the structural diversity of NMDA receptors across species and the variations among receptor subtypes within the same species remain insufficiently explored. Additionally, several key small molecule binding sites, such as those for agonists, antagonists, and allosteric modulators, have not been fully characterized. In this study, we utilized state-of-the-art artificial intelligence algorithms to model NMDA receptors across multiple species and found that they all adopted a bouquet-like dimer-of-dimer structure. By comparing these models with cryo-EM resolved structures, we assessed the accuracy of the predictions and complemented the structural data with detailed models of transmembrane domain regions, which are traditionally challenging for experimental methods. Furthermore, through the integration of AI-based prediction tools and molecular dynamic simulations, we highlighted potential binding sites for agonists, competitive antagonists, and pore blockers at amino acid resolution. This AI-enhanced approach builds traditional structural biology techniques, revealing that NMDA receptors from different species adopt highly similar three-dimensional architectures, while also exhibiting subtype-specific structural features. Furthermore, our identification of ligand binding pockets at the amino acid resolution provides a more detailed understanding of receptor-ligand interactions, offering potential templates for rational drug design and optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.